Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.1885
-0.0115 (-5.75%)
At close: Jul 2, 2025, 4:00 PM
0.1885
0.00 (0.00%)
Pre-market: Jul 3, 2025, 8:25 AM EDT
PCSA's stock price has decreased by -90.98% in the past year and price targets may not have had time to catch up.
Processa Pharmaceuticals Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$2.00
Upside
+961.01%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $2 | Strong Buy | Maintains | $6 → $2 | +961.01% | Jun 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +3,083.02% | Dec 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +3,083.02% | Oct 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +3,083.02% | Aug 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $6 | Strong Buy | Maintains | $8 → $6 | +3,083.02% | Aug 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +4,144.03% | Aug 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +4,144.03% | Jun 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +4,144.03% | May 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +4,144.03% | Apr 25, 2024 |
| Benchmark | Benchmark | Buy Reiterates $4 | Buy | Reiterates | $4 | +2,022.02% | Mar 6, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 17, 2023 |
| Benchmark | Benchmark | Buy Maintains $180 → $80 | Buy | Maintains | $180 → $80 | +42,340.32% | Apr 4, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $100 → $60 | Buy | Maintains | $100 → $60 | +31,730.24% | Apr 3, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $180 → $100 | Strong Buy | Maintains | $180 → $100 | +52,950.40% | Jan 12, 2023 |
| Maxim Group | Maxim Group | Strong Buy Initiates $180 | Strong Buy | Initiates | $180 | +95,390.72% | Apr 19, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $400 | Buy | Initiates | $400 | +212,101.59% | Aug 3, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.